Validation of a Food Frequency Questionnaire for the Assessment of Omega-3 Fatty Acid Intake
1 other identifier
observational
152
1 country
1
Brief Summary
As essential nutrients omega 3 fatty acids contribute to normal growth and development. Inadequate intake is linked to the development of chronic diseases such as coronary heart disease, high blood pressure, cancer, arthritis, psychological illnesses and allergies. Therefore, it is important to be able to reliably detect the intake of these fatty acids. Due to eating habits varying in different countries the questionnaire documenting dietary habits needs to be adapted to the situation in question. Based on a US version the investigators developed a questionnaire suitable for Switzerland and now wish to validate it by measuring the fatty acid composition of red blood cells, which will provide information on the intake of the various fatty acids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedFirst Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2018
CompletedJuly 26, 2018
July 1, 2018
6 months
January 18, 2018
July 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Fatty acid composition of red blood cells due to dietary habits
Fatty acid composition of red blood cells due to dietary habits
1 day ( first visit)
Interventions
no intervention (observational study)
Eligibility Criteria
Healthy adults
You may qualify if:
- healthy males and females aged 18 to 60
You may not qualify if:
- known disorders of the gastrointestinal tract which can lead to malabsorption
- intake of medication which could affect the absorption of any nutrients
- Pregnant or breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Isabelle Herter-Aeberlilead
- University Children's Hospital, Zurichcollaborator
Study Sites (1)
ETH Zurich
Zurich, 8092, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
January 18, 2018
First Posted
January 24, 2018
Study Start
January 15, 2018
Primary Completion
July 25, 2018
Study Completion
July 25, 2018
Last Updated
July 26, 2018
Record last verified: 2018-07